Clinical Trial Update: Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 [Phase 2]

View source ↗

Summary

This document reports the results of a Phase II trial of everolimus (RAD001) in children and adults with Neurofibromatosis Type 2; the study is completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type Ii

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: NYU Langone Health | Conditions: Neurofibromatosis Type II | Phase 2 | Status: COMPLETED | Results posted: 2015-08-07